Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression

Citations Over TimeTop 10% of 2017 papers

Abstract

Local interactions between cancer cells and stroma can produce systemic effects on distant organs to govern cancer progression. Here we show that IGF2 secreted by inhibitor of differentiation (Id1)-overexpressing oesophageal cancer cells instigates VEGFR1-positive bone marrow cells in the tumour macroenvironment to form pre-metastatic niches at distant sites by increasing VEGF secretion from cancer-associated fibroblasts. Cancer cells are then attracted to the metastatic site via the CXCL5/CXCR2 axis. Bone marrow cells transplanted from nude mice bearing Id1-overexpressing oesophageal tumours enhance tumour growth and metastasis in recipient mice, whereas systemic administration of VEGFR1 antibody abrogates these effects. Mechanistically, IGF2 regulates VEGF in fibroblasts via miR-29c in a p53-dependent manner. Analysis of patient serum samples showed that concurrent elevation of IGF2 and VEGF levels may serve as a prognostic biomarker for oesophageal cancer. These findings suggest that the Id1/IGF2/VEGF/VEGFR1 cascade plays a critical role in tumour-driven pathophysiological processes underlying cancer progression.

Related Papers

• → Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors(2007)71 cited
• Clinical Application of Endothelial Progenitor Cell: Are We Ready?(2013)
• → Circulating Committed and Pluripotent Haemopoietic Progenitor Cells, in Infants(1986)17 cited
• → Gender dimorphisms in endotoxin-stimulated progenitor cell function(2006)
• Stem/Progenitor Cells and Atherosclerosis(2011)